Search Results 1631-1640 of 20013 for Hepatitis b

1. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

   ... hepatitis B virus surface antigen (HBV sAg+), active Hepatitis C (if antibody [Ab]+ then polymerase chain reaction [PCR]+) indicating acute or chronic ...

2. A Study of APR-246 and Pembrolizumab in Patients with Solid Tumor Malignancies - Mayo Clinic

   Known history of untreated human immunodeficiency virus (HIV)/HIV with a detectable viral load or active hepatitis B or active hepatitis C infection. Any of ...

3. First In Human Study Of KO-539 To Treat Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Patient has a known positive test for human immunodeficiency virus, hepatitis C, or hepatitis B surface antigen indicative of active infection. Patient has ...

4. Oatd-01, An Oral Inhibitor Of Chitinase-1 (CHIT1), For The Treatment Of Active Pulmonary Sarcoidosis - Mayo Clinic

   Known positivity for Human Immunodeficiency Virus (HIV 1/2 antibodies), hepatitis B virus, or hepatitis C virus. Patients with psychiatric disorder that ...

5. Francis A. Farraye, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   ... hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD. Mayo Clinic locations · Jax. Jacksonville ...

6. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

   Any positive test for hepatitis B virus or hepatitis C virus indicating acute or chronic infection; Known history of testing positive for Human ...

7. A Study Comparing Orteronel Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer, who have not had Chemotherapy - Mayo Clinic

   ... hepatitis B, or hepatitis C; Unwilling or unable to comply with protocol; Uncontrolled nausea, vomiting or diarrhea; Known gastrointestinal disease or ...

8. A Study of Vutrisiran (ALN-TTRSC02) in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) - Mayo Clinic

   Has known human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) infection. Received an experimental drug within 30 days of ...

9. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

   Evidence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Active and uncontrolled infectious disease requiring systemic antibiotic ...

10. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    ... hepatitis B (defined as ALT > 1 x ULN, and HBV DNA >2000 IU/ml), or hepatitis C (defined as ALT > 1 x ULN, persistent viremia on antiviral therapy) infections ...